NYSEARCA:LABU

Labu ETF News

etoro logo Buy LABU
*Your capital is at risk
$158.16
-23.51 (-12.94%)
At Close: Jun 02, 2026
If you bought XBI a year ago and held it, you are up roughly 65%. If you bought Direxion Daily S&P Biotech Bull 3X Shares (NYSEARCA:LABU) on the same day, you are up about 235%.
Biotech has reasserted itself over the past year as drug approvals,
JPMorgan Chase and Co. purchased a new stake in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) in the third quarter, according to its most recent Form 13F filing with the Securities and Exc
Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU - Get Free Report) gapped down prior to trading on Friday. The stock had previously closed at $170.74, but opened at $164.08. Direxion Daily S&
Triple-leveraged ETFs aren't for everyone, but if you believe biotech is about to break out, Direxion Daily S&P Biotech Bull 3X Shares (NASDAQ:LABU) offers the most aggressive way to capture that move
Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU - Get Free Report)'s stock price hit a new 52-week high during mid-day trading on Thursday. The company traded as high as $186.25 and last trad
Although the equities market often embodies chaos and capricious non-linearity, few sectors witness as much kinetic wildness like biotechnology. At its core, biotech represents an innovative push towa
Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU - Get Free Report) shares hit a new 52-week high during mid-day trading on Friday. The company traded as high as $169.50 and last traded at $16

Top Performing Leveraged/Inverse ETFs: 11/16/2025

01:45pm, Wednesday, 19'th Nov 2025
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

New FDA Director Could Sway Biotech ETFs

01:35pm, Friday, 14'th Nov 2025
Biotech stocks could sway toward the upside with the appointment of a new director at the Federal Drug Administration's Center for Drug Evaluation and Research. Dr. Richard Pazdur will take the reigns

Follow Signals, Don't Chase Price - JD Henning

07:00am, Wednesday, 08'th Oct 2025
JD Henning, who runs Value and Momentum Breakouts, shares why following market signals is so important. Leveraging quantitative signals and sector rotation for strong returns.
After a relatively sluggish 2024 for mergers & acquisitions (M&A) activity in the biopharma sector, the environment could be more conducive for deals in the rest of 2025. The industry, like the rest o
Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE